The evidence summarized in Chapter 1, served as the rationale for the studies presented in this thesis. The questions addressed in this thesis are: - In chapter 3, we addressed the idea that sympathetic activity in CKD patients is related to cardiovascular organ damage. We hypothesized that patients with chronic kidney disease have agreater left ventricular mass than healthy volunteers independent of blood pressure and that MSNAis positively correlated to left ventricular mass; - In chapter 4, we studied the effect of the renin inhibitor aliskiren on MSNA. We hypothesized that aliskiren effectively lowers sympathetic activity in CKD patients. In addition, in this chapter we will look at the effect of 100% oxygen administration on sympathet...
Much evidence indicates increased sympathetic nervous activity (SNA) in renal disease. Renal ischemi...
Background: Patients with chronic kidney disease (CKD) who undergo chronic haemodialysis (HD) show a...
Hypertension is common in chronic kidney disease (CKD)patients [1–4]. Its prevalence varies between ...
Sympathetic hyperactivity in patients with chronic kidney disease Chronic kidney disease (CKD) is of...
The incidence of chronic kidney disease (CKD) is increasing worldwide, with more than 26 million peo...
Sympathetic nervous system plays a crucial role in the development of cardiovascular complications i...
Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment...
The general objective of this thesis was to determine which patients are most likely to benefit most...
Cardiovascular autonomic dysfunction is a major complication of chronic kidney disease (CKD), likely...
Empirical thesis.Bibliography: 155-209.1. Literature review -- 2. Respiratory sympathetic modulation...
Item does not contain fulltextCardiovascular morbidity and mortality importantly influence live expe...
Chronic kidney disease is often characterized by the presence of sympathetic hyperactivity. The aim ...
Background: Impaired peripheral chemoreflex sensitivity has been suggested to contribute to sympathe...
Hypertension is common in patients with polycystic kidney disease (PKD). This study addresses the hy...
Hypertension is common in chronic renal failure (CRF). It is an important cardiovascular risk factor...
Much evidence indicates increased sympathetic nervous activity (SNA) in renal disease. Renal ischemi...
Background: Patients with chronic kidney disease (CKD) who undergo chronic haemodialysis (HD) show a...
Hypertension is common in chronic kidney disease (CKD)patients [1–4]. Its prevalence varies between ...
Sympathetic hyperactivity in patients with chronic kidney disease Chronic kidney disease (CKD) is of...
The incidence of chronic kidney disease (CKD) is increasing worldwide, with more than 26 million peo...
Sympathetic nervous system plays a crucial role in the development of cardiovascular complications i...
Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment...
The general objective of this thesis was to determine which patients are most likely to benefit most...
Cardiovascular autonomic dysfunction is a major complication of chronic kidney disease (CKD), likely...
Empirical thesis.Bibliography: 155-209.1. Literature review -- 2. Respiratory sympathetic modulation...
Item does not contain fulltextCardiovascular morbidity and mortality importantly influence live expe...
Chronic kidney disease is often characterized by the presence of sympathetic hyperactivity. The aim ...
Background: Impaired peripheral chemoreflex sensitivity has been suggested to contribute to sympathe...
Hypertension is common in patients with polycystic kidney disease (PKD). This study addresses the hy...
Hypertension is common in chronic renal failure (CRF). It is an important cardiovascular risk factor...
Much evidence indicates increased sympathetic nervous activity (SNA) in renal disease. Renal ischemi...
Background: Patients with chronic kidney disease (CKD) who undergo chronic haemodialysis (HD) show a...
Hypertension is common in chronic kidney disease (CKD)patients [1–4]. Its prevalence varies between ...